ESR1 and breast cancer: Taken together, these findings demonstrate that elevated levels of type I IFNs in the breast tumor microenvironment led to IFI16-mediated aromatase activation and E2 production in adipose tissue surrounding BC, supporting the E2-dependent growth of ER-positive BC cells (Fig. 8c).